Valion Bio VBIO 深 沪
已收盘 10-09 16:00:00 美东时间
2.14
-0.070
-3.17%
华盛通- 最 高2.2699
- 今 开2.19
- 成交量 14.06万股
- 最 低 2.10
- 昨 收 2.21
- 总市值 275.12万
- 52周最高 76.50
- 市盈率 静 --
- 换手率 10.93%
- 52周最低 2.05
- 委 比 -63.64%
- 总股本 128.56万
- 历史最高 276250.00
- 量 比 0.73
- 振 幅 7.69%
- 历史最低 2.10
- 每 手 1
- 风险率 19.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Valion Bio Secures Additional Series B Preferred Financing
An update from Valion Bio ( ($VBIO) ) is now available. On October 7, 2026, Val...
10-08 18:29
Valion Bio shares are trading higher after the company announced the completion of formulation work under the company's ongoing program to develop a novel oral mucosal formulation of Entolimod with Shear Kershman Laboratories.
Valion Bio shares are trading higher after the company announced the completion of formulation work under the company's ongoing program to develop a novel oral mucosal formulation of Entolimod with Shear Kershman Laboratories.
10-01 02:08
Valion Bio Appoints Dean Zikria Interim CEO, Thomas Jensen As Board Chair
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company, today announced decisive changes to its executive leadership team and Board of Directors (the "Board"). These leadership transitions are intended to strengthen organizational alignment and support...
09-23 20:02
Valion Bio Appoints Lisa Wolf To Expanded Roles Of President, COO, Effective Immediately
Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company, today announced strategic changes to its management team and Board of Directors designed to accelerate execution across its clinical and commercial initiatives and position the Company for its nex...
09-01 20:09
Valion Bio raises capital via new preferred financing
The latest update is out from Valion Bio ( ($VBIO) ). On August 31, 2026, Valio...
09-01 18:29
Valion Bio Announces 1-For-25 Reverse Stock Split, Effective Aug. 31
Valion Bio, Inc. (Nasdaq:VBIO) ("Valion Bio" or the "Company) announced today that its Board of Directors has declared a 1-for-25 reverse stock split of the Company's issued and outstanding shares of common stock. The purpose of the reverse stock split is to bring the Company into compliance with th...
08-27 20:32
Why Cadeler Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Cadeler A/S – ADR (NYSE:CDLR) rose sharply in pre-market trading after the company reported interim financial results for the first half of 2026. Revenue for the first six months of 2026 jumped to EUR 408 million from EUR 188 million in the year-ago period. Profit for the period climbed 54...
08-25 17:25
Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of Cadeler A/S – ADR (NYSE:CDLR) rose sharply in pre-market trading after the company reported interim financial results for the first half of 2026. Revenue for the first six months of 2026 jumped to EUR 408 million from EUR 188 million in the year-ago period. Profit for the period climbed 54...
08-25 17:25
Valion Bio To Carry Out Study At Sheba Medical Center To Mull Entolimod In 10 Cancer Participants
Valion Bio, Inc. (NASDAQ:VBIO) today announced a major clinical development milestone with the finalization of an clinical trial protocol at Sheba Medical Center, one of the world's leading hospitals, to evaluate Entolimod in cancer patients receiving high doses of irradiation for a rare form of can...
07-21 01:35
Valion Bio Q1 2026 Earnings Call: Complete Transcript
On Thursday, Valion Bio (NASDAQ:VBIO) discussed first-quarter financial results...
05-15 05:20
